Anti-diabetic Effect of Watermelon Seed Powder in the Management of Diabetes in Ghana.

Anti-diabetic Effect of Watermelon Seed Powder in the Management of Type 2 Diabetes in Ghana: A Pilot Single-Blinded Randomised Control Trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

PACTR

Registry ID

PACTR202509519573555

Enrollment

132

Registered

2025-09-16

Start date

2025-10-13

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine

Interventions

Watermelon Seed Powder Supplementation in Adults with Type 2 Diabetes

No name assign

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Medically diagnosed type 2 diabetic patients Patients should be 18 years and above Patients without diabetes related complications

Exclusion criteria

Exclusion criteria: Type 1 diabetic patients Type 2 diabetic patients who are below 18 years Type 2 diabetic patients with diabetes related complications

Design outcomes

Primary

Measure	Time frame
Changes in fasting blood glucose and HbA1C	—

Secondary

Measure	Time frame
Changes in total Lipid Profile, BMI, Blood Pressure	—

Countries

Ghana

Contacts

Public ContactCharles Apprey

Senior lecturer KNUST

appreycharles@gmail.com+233243826275

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026